New treatments for melanoma and skin cancer
Melanoma and Skin Cancer Program SPORE
This study is looking for new and better ways to treat melanoma and skin cancer for patients who haven't had success with current treatments, including trying out a special device that delivers chemotherapy through tiny needles.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10926821 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies for melanoma and cutaneous squamous cell carcinoma (cSCC), which are among the most common cancers in the U.S. The program aims to create new combinatorial immunotherapy trials that could improve treatment outcomes for patients who have not responded to existing therapies. It includes evaluating the effectiveness of new drugs and treatment methods, such as a microneedle device for delivering chemotherapy. Patients will be involved in clinical trials that assess the safety and efficacy of these novel approaches.
Who could benefit from this research
Good fit: Ideal candidates for participation are patients with advanced melanoma or cSCC who have not previously received immunotherapy.
Not a fit: Patients with early-stage melanoma or cSCC who are not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for patients with melanoma and skin cancer.
How similar studies have performed: Previous research has shown promise in using combinatorial immunotherapy approaches for melanoma, indicating potential for success in this novel application.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Zarour, Hassane M — University of Pittsburgh at Pittsburgh
- Study coordinator: Zarour, Hassane M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.